NO20021950L - Fremgangsmåte for fremstilling av N-(4,5-bis-metansulfonyl-2- metylbenzoyl)-guanidin-hydroklorid - Google Patents

Fremgangsmåte for fremstilling av N-(4,5-bis-metansulfonyl-2- metylbenzoyl)-guanidin-hydroklorid

Info

Publication number
NO20021950L
NO20021950L NO20021950A NO20021950A NO20021950L NO 20021950 L NO20021950 L NO 20021950L NO 20021950 A NO20021950 A NO 20021950A NO 20021950 A NO20021950 A NO 20021950A NO 20021950 L NO20021950 L NO 20021950L
Authority
NO
Norway
Prior art keywords
methylbenzoyl
preparation
methanesulfonyl
bis
guanidine hydrochloride
Prior art date
Application number
NO20021950A
Other languages
English (en)
Other versions
NO328250B1 (no
NO20021950D0 (no
Inventor
Rolf Gericke
Manfred Baumgarth
Hans Markus Bender
Bernhard Ladstetter
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of NO20021950D0 publication Critical patent/NO20021950D0/no
Publication of NO20021950L publication Critical patent/NO20021950L/no
Publication of NO328250B1 publication Critical patent/NO328250B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C315/00—Preparation of sulfones; Preparation of sulfoxides
    • C07C315/04—Preparation of sulfones; Preparation of sulfoxides by reactions not involving the formation of sulfone or sulfoxide groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C315/00—Preparation of sulfones; Preparation of sulfoxides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cardiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20021950A 1999-10-26 2002-04-25 Fremgangsmate for fremstilling av N-(4,5-bis-metansulfonyl-2-metylbenzoyl)-guanidin-hydroklorid NO328250B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19951418A DE19951418A1 (de) 1999-10-26 1999-10-26 Verfahren zur Herstellung von N-(4,5-Bismethansulfonyl-2-methyl-benzoyl) -guanidin, Hydrochlorid
PCT/EP2000/009977 WO2001030750A1 (de) 1999-10-26 2000-10-11 Verfahren zur herstellung von n-(4,5-bis-methansulfonyl-2-methyl-benzoyl)-guanidin, hydrochlorid

Publications (3)

Publication Number Publication Date
NO20021950D0 NO20021950D0 (no) 2002-04-25
NO20021950L true NO20021950L (no) 2002-04-25
NO328250B1 NO328250B1 (no) 2010-01-18

Family

ID=7926842

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20021950A NO328250B1 (no) 1999-10-26 2002-04-25 Fremgangsmate for fremstilling av N-(4,5-bis-metansulfonyl-2-metylbenzoyl)-guanidin-hydroklorid

Country Status (26)

Country Link
US (1) US6673968B1 (no)
EP (1) EP1224166B1 (no)
JP (1) JP4969750B2 (no)
KR (1) KR100699571B1 (no)
CN (1) CN1202078C (no)
AT (1) ATE250026T1 (no)
AU (1) AU782471B2 (no)
BR (1) BR0015022A (no)
CA (1) CA2388915C (no)
CZ (1) CZ299201B6 (no)
DE (2) DE19951418A1 (no)
DK (1) DK1224166T3 (no)
ES (1) ES2204712T3 (no)
HK (1) HK1051358A1 (no)
HU (1) HU228634B1 (no)
MX (1) MXPA02004144A (no)
MY (1) MY122651A (no)
NO (1) NO328250B1 (no)
PL (1) PL199010B1 (no)
PT (1) PT1224166E (no)
RU (1) RU2276134C2 (no)
SI (1) SI1224166T1 (no)
SK (1) SK286603B6 (no)
UA (1) UA73329C2 (no)
WO (1) WO2001030750A1 (no)
ZA (1) ZA200204119B (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10023405A1 (de) * 2000-05-12 2001-11-15 Merck Patent Gmbh Verfahren zur Herstellung von Sulfonyl-benzoylguanidinum-Salzen
KR20060015580A (ko) * 2003-05-06 2006-02-17 메르크 파텐트 게엠베하 구아니디늄 염의 결정화 방법
AU2009243749B2 (en) 2008-05-09 2013-11-21 Merck Patent Gmbh Pharmaceutical composition comprising rimeporide for treating diseases associated with insulin resistance and beta-cell dysfunction
JOP20200296A1 (ar) * 2013-06-10 2017-06-16 Amgen Inc عمليات صنع وأشكال بلورية من mdm2 مثبط
SG11201610815PA (en) * 2014-06-23 2017-02-27 Nissan Chemical Ind Ltd Method for producing silane compound having sulfonyl bond
JP7050005B2 (ja) 2016-02-08 2022-04-07 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング Ｎ－（４，５－ビスメタンスルホニル－２－メチルベンゾイル）グアニジン塩酸塩およびｎ－（４，５－ビスメタンスルホニル－２－メチルベンゾイル）グアニジン塩の結晶変態
EP3960165A1 (en) * 2020-08-25 2022-03-02 Fondation EspeRare Nhe-1 inhibitors for the treatment of coronavirus infections

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59216865A (ja) * 1983-05-26 1984-12-06 Mitsui Toatsu Chem Inc システイン塩酸塩水和物の乾燥方法
DE3929582A1 (de) * 1989-09-06 1991-03-07 Hoechst Ag Benzoylguanidine, verfahren zu ihrer herstellung, ihre verwendung als medikament sowie sie enthaltendes medikament
ATE147375T1 (de) * 1992-09-22 1997-01-15 Hoechst Ag Benzoylguanidine, verfahren zu ihrer herstellung, sowie ihre verwendung als antiarrhythmika
EP0604852A1 (de) * 1992-12-28 1994-07-06 Hoechst Aktiengesellschaft 2,4-Substituierte 5-(N-substituierte-Sulfamoyl)-Benzoylguanidine, als Antiarrythmika, Inhibitoren der Proliferationen von Zellen, und Inhibitoren des Natrium-Protonen-Antiporters
JPH07206857A (ja) * 1993-12-28 1995-08-08 Synthelabo Sa アルフゾシン塩酸塩の二水和物
JP3755908B2 (ja) * 1994-08-17 2006-03-15 塩野義製薬株式会社 セファロスポリン化合物の晶析法
DK0723956T3 (da) * 1995-01-30 2000-04-17 Hoechst Ag Basisk substituerede benzoylguanidiner, fremgangsmåde til fremstilling deraf, anvendelse deraf som lægemiddel eller diagnos
DE19502895A1 (de) * 1995-01-31 1996-08-01 Merck Patent Gmbh 4-Mercapto-benzoylguanidin-Derivate
DE19529612A1 (de) * 1995-08-11 1997-02-13 Merck Patent Gmbh Sulfonyl- oder Sulfinyl-benzoylguanidin-Derivate

Also Published As

Publication number Publication date
CA2388915C (en) 2009-12-15
DE19951418A1 (de) 2001-05-03
NO328250B1 (no) 2010-01-18
MXPA02004144A (es) 2006-01-12
SI1224166T1 (en) 2004-04-30
WO2001030750A1 (de) 2001-05-03
ES2204712T3 (es) 2004-05-01
EP1224166A1 (de) 2002-07-24
US6673968B1 (en) 2004-01-06
SK5462002A3 (en) 2002-10-08
CZ20021354A3 (cs) 2002-09-11
JP2003512451A (ja) 2003-04-02
BR0015022A (pt) 2002-06-18
RU2276134C2 (ru) 2006-05-10
ATE250026T1 (de) 2003-10-15
CN1202078C (zh) 2005-05-18
DE50003759D1 (de) 2003-10-23
AU782471B2 (en) 2005-08-04
SK286603B6 (sk) 2009-02-05
PL199010B1 (pl) 2008-08-29
HK1051358A1 (en) 2003-08-01
AU1136101A (en) 2001-05-08
HU228634B1 (en) 2013-04-29
KR20020044572A (ko) 2002-06-15
JP4969750B2 (ja) 2012-07-04
CZ299201B6 (cs) 2008-05-14
CA2388915A1 (en) 2001-05-03
ZA200204119B (en) 2003-10-29
KR100699571B1 (ko) 2007-03-23
MY122651A (en) 2006-04-29
UA73329C2 (uk) 2005-07-15
HUP0203132A2 (hu) 2003-01-28
DK1224166T3 (da) 2004-01-05
EP1224166B1 (de) 2003-09-17
CN1382120A (zh) 2002-11-27
NO20021950D0 (no) 2002-04-25
HUP0203132A3 (en) 2004-12-28
PT1224166E (pt) 2004-02-27
PL355149A1 (en) 2004-04-05

Similar Documents

Publication Publication Date Title
ATE269312T1 (de) N-(amidinophenyl)-n'-(subst.)-3h-2,4- benzodiazepin-3-on derivative als faktor xa inhibitoren
DE60236102D1 (en) 1h-indolderivate als hochselektive cyclooxygenase-2-inhibitoren
DK0977741T3 (da) Substituerede phenylderivater, deres fremstilling og anvendelse
RS51444B (sr) JEDINJENJA KOJA SADRŽE LAKTAM I NJIHOVI DERIVATI KAO INHIBITORI FAKTORA Xa
DK0850221T3 (da) Meta-guanidin-, urinstof-, thiourinstof- eller azacykliske aminobenzoesyrederivater som intergrinantagonister
LV12496A (en) Novel guanidine mimics as factor xa inhibitors
GT200000103A (es) Trifluorbutenos nematocidas.
RS51477B (en) SUBSTITUTED ALKYLAMINE DERIVATIVES AND PROCEDURES FOR THEIR USE
NO20043016L (no) 6-aminomorfinan-derivater, fremgangsmate for fremstilling og anvendelse derav
CY1108224T1 (el) Καινοτομες κρυσταλλικες μορφες ενος αναστολεα του παραγοντα χα
NO20021950D0 (no) Fremgangsmåte for fremstilling av N-(4,5-bis-metansulfonyl-2- metylbenzoyl)-guanidin-hydroklorid
ATE348800T1 (de) 4'-methansulfonylbiphenylderivate als hochselektive cyclooxygenase-2-inhibitoren
ATE223405T1 (de) Modifizierte form des hydrochlorids der r(-)-n-(4,4-di(-3-methylthien-2-yl)but-3-enyl)- nipecotinsäure
ATE427934T1 (de) Nicht-peptidische brs-3-agonisten
ATE242763T1 (de) Methoximinophenylessigsäureamide
DE60043228D1 (de) Herstellungsverfahren von 2-cyanopyridinen
DE59803066D1 (de) Substituierte benzyloxyimino-verbindungen
DK1246790T3 (da) Substituerede 1- og 2-naphthol-Mannichbaser
ES2128031T3 (es) Forma cristalina y polimorfica de (s,s,s)-n-(1-(2-carboxi-3-(n2-mesilisilamino)propil)-1-ciclopentilcarbonil)tirosina.
AR026231A1 (es) Proceso para preparar clorhidrato de n-(4,5-bis-metansulfonil-2-metilbenzoil)-guanidina
NO20021821L (no) Natrium-hydrogen utvekslingstype 1 inhibitor krystaller
NO20030606D0 (no) Modifisert gj¶r og anvendelser derav, n¶rmere bestemt for fremstilling avsteroidderivater
DE69929315D1 (de) Kristalline formen von 1s-ä1alpha(2s*,3r*),9alphaü-6,10-dioxo-n- (2-ethoxy-5-oxo-tetrahydro-3-furanyl)-9-ää(1-isochinolyl)carbonylü- aminoüoctahydro-6h-piridazinoä1,2-aüä1,2üdiazepin-1-carboxyamid
ITMI920720A1 (it) Forma cristallina dell'endo-3-etil-2, 3-diidro-n-(8-metil-8-azabiciclo (3. 2. 1) ott-3-il)- 2-oxo-1h-benzimidazolo-1-carbossamide cloridrato
MX9708155A (es) Inhibicion de la fotodescomposicion de 2-oxindoles 3-sustituidos.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees